SecBot SecBot

ADTX

Aditxt, Inc.
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001726711 Biotech & Drug Discovery
$0.001000 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $0.001000
1 year
−100.0%
from $5,247.72 · Oct 24
30 days
−80.0%
from $0.005000
52-week range
$0.001000–5,247.72
−100% from high · low Oct 16
Avg volume 20D
11.27M
Oct 15 spike 34.01M
Short interest
898.2K
+0.1%
Days to cover
1.0
at average volume
Insider net
+$28.4K
2 buyers · 5 sellers · 12 mo
Filing reports
20
analyzed by SecBot
SecBot read BEARISH 3 reports · 90 days
Balance 3 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 3/3 ·Next Earnings date, Nov 16, 2026
Strongest BEARISH Nasdaq filed a Form 25-NSE to complete the delisting of Aditxt, Inc. common stock, effective October 19…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersMIXED

    2 insiders bought $364.8K at an average $0.0217. 5 insiders sold $336.4K. Price is 95% below their cost.

  • Short sellersSTEADY

    Short interest +0.1% to 898.2K shares. 1.0 days to cover.

  • TrendDOWNTREND

    77% below its 50-day average. New closing low $0.001000 on Oct 23.

The Street

last action Sep 2023
Recent actions
DateFirmActionRating
Sep 6, 2023HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 16, 2026
Earnings date
🔒 Fresh data — subscribers only
Recent
Aug 12, 2026
Earnings date
ADTX Q2 2026 Earnings Scheduled — 2026-08-12
May 13, 2026
Earnings date
ADTX Q1 2026 Earnings Scheduled — 2026-05-13
Mar 23, 2026
Earnings date
ADTX Q4 2025 Earnings Before Market Open — 2026-03-23

Insider ledger

Form 4
$364.8K
bought · 2 insiders
$336.4K
sold · 5 insiders
−95.4%
vs their $0.0217 cost
DateInsiderTypeValue
Jun 23, 2026
Takeover Time 2026 LLC
10%+ Owner
SELL$68.4K
Jun 22, 2026
HRT FINANCIAL LP
10%+ Owner
SELL$92.2K
Jun 18, 2026
HRT FINANCIAL LP
10%+ Owner
BUY$95.4K
Jun 17, 2026
DRW Securities, LLC
10%+ Owner
SELL$1.0K
Jun 16, 2026
HRT FINANCIAL LP
10%+ Owner
SELL$40.7K
Jun 15, 2026
HRT FINANCIAL LP
10%+ Owner
BUY$29.6K
Jun 12, 2026
HRT FINANCIAL LP
10%+ Owner
BUY$68.0K
Jun 11, 2026
HRT FINANCIAL LP
10%+ Owner
SELL$39.7K

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
898,241
shares short
+0.1%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 SEC
Aditxt's wholly-owned subsidiary Ignite Proteomics mutually terminated its Business Combination Agreement with SPAC…
8-K — Impact 6/10
Oct 7, 2026 SEC
Nasdaq filed a Form 25-NSE to complete the delisting of Aditxt, Inc. common stock, effective October 19, 2026. The…
25-NSE — Impact 8/10
Sep 23, 2026 SEC
Nasdaq has formally announced it will file a Form 25 with the SEC to complete the delisting of Aditxt's common stock…
8-K — Impact 8/10
Aug 12, 2026 Earnings calendar
ADTX Q2 2026 Earnings Scheduled — 2026-08-12
Jun 23, 2026 Insider
Takeover Time 2026 LLC sold 3,420,439 shares
10%+ Owner @ $0.0200 ($68.4K)
Jun 22, 2026 Insider
HRT FINANCIAL LP sold 5,120,480 shares
10%+ Owner @ $0.0180 ($92.2K)
Jun 18, 2026 Insider
HRT FINANCIAL LP bought 7,340,178 shares
10%+ Owner @ $0.0130 ($95.4K)

SecBot reports

20 filings · 1 bullish · 11 bearish · 1 mixed · 7 neutral
All ADTX filing & press-release reports (28)